Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic T Moore

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.
Cancer|June 16, 2018
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancerHanna K Sanoff, Richard M Goldberg, Anastasia Ivanova, et al.
Journal for Immunotherapy of Cancer|February 5, 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, et al.
Archives of Pathology & Laboratory Medicine|May 1, 2018
Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent ClassificationsWilliam K Funkhouser, D Neil Hayes, Dominic T Moore, et al.
Archives of Pathology & Laboratory Medicine|May 16, 2012
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsetsJuneko E Grilley-Olson, D Neil Hayes, Dominic T Moore, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
The Lancet. Haematology|March 31, 2024
Anti-CD30 CAR T cells as consolidation after autologous haematopoietic stem-cell transplantation in patients with high-risk CD30<sup>+</sup> lymphoma: a phase 1 studyNatalie S Grover, George Hucks, Marcie L Riches, et al.
Cancer|June 16, 2018
Multicenter, randomized, double-blind phase 2 trial of FOLFIRI with regorafenib or placebo as second-line therapy for metastatic colorectal cancerHanna K Sanoff, Richard M Goldberg, Anastasia Ivanova, et al.
Journal for Immunotherapy of Cancer|February 5, 2022
Evaluating the efficacy of a priming dose of cyclophosphamide prior to pembrolizumab to treat metastatic triple negative breast cancerCarey K Anders, Mark G Woodcock, Amanda E D Van Swearingen, et al.
Archives of Pathology & Laboratory Medicine|May 1, 2018
Interpathologist Diagnostic Agreement for Non-Small Cell Lung Carcinomas Using Current and Recent ClassificationsWilliam K Funkhouser, D Neil Hayes, Dominic T Moore, et al.
Archives of Pathology & Laboratory Medicine|May 16, 2012
Validation of interobserver agreement in lung cancer assessment: hematoxylin-eosin diagnostic reproducibility for non-small cell lung cancer: the 2004 World Health Organization classification and therapeutically relevant subsetsJuneko E Grilley-Olson, D Neil Hayes, Dominic T Moore, et al.
Pageof 11